{
    "clinical_study": {
        "@rank": "102497", 
        "arm_group": [
            {
                "arm_group_label": "ISIS-GCGRRx Group 1", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "ISIS-GCGRRx Group 2", 
                "arm_group_type": "Experimental"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the efficacy, safety and tolerability of\n      ISIS-GCGRRx in combination with metformin versus placebo + metformin"
        }, 
        "brief_title": "Safety, Tolerability and Efficacy of ISIS-GCGRRx in Type 2 Diabetes", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Type 2 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 2"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, age 18 to 75\n\n          -  BMI greater than or equal to 25\n\n          -  HbA1c greater than or equal to 7.5% and less than or equal to 10.5%\n\n          -  Type 2 Diabetes Mellitus and on stable dose of oral metformin\n\n          -  Agree to conduct home-based (fasted) blood glucose testing as directed\n\n        Exclusion Criteria:\n\n          -  Clinically significant abnormalities in medical history or physical exam\n\n          -  Show evidence of uncorrected hypothyroidism or hyperthyroidism hormone results\n\n          -  History of renal transplantation or renal dialysis\n\n          -  History of liver disease\n\n          -  History of greater than 3 episodes of severe hypoglycemia within 6 months of\n             screening\n\n          -  Use of oral anti-diabetic medication other than metformin within 3 months of\n             screening\n\n          -  History of diabetic ketoacidosis\n\n          -  Any other significant illness or condition that may interfere with the patient\n             participating or completing the study\n\n          -  Inability or unwillingness to comply with protocol or study procedures"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "72", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 13, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01885260", 
            "org_study_id": "ISIS 449884-CS2"
        }, 
        "intervention": [
            {
                "arm_group_label": "ISIS-GCGRRx Group 1", 
                "description": "3 doses on alternate days during the first week and then once weekly for 12 weeks + daily metformin", 
                "intervention_name": "ISIS-GCGRRx - Dose Level 1", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "ISIS-GCGRRx Group 2", 
                "description": "3 doses on alternate days during the first week and then once weekly for 12 weeks + daily metformin", 
                "intervention_name": "ISIS-GCGRRx - Dose Level 2", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "3 doses on alternate days during the first week and then once weekly for 12 weeks + daily metformin", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Type 2 Diabetes Mellitus", 
            "T2DM"
        ], 
        "lastchanged_date": "November 12, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35216"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Muscle Shoals", 
                        "country": "United States", 
                        "state": "Alabama", 
                        "zip": "35662"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Anaheim", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "92801"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chino", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "91710"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Los Angeles", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "90057"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Deland", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "32720"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ft. Lauderdale", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33306"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida", 
                        "zip": "33143"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Marietta", 
                        "country": "United States", 
                        "state": "Georgia", 
                        "zip": "30066"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Las Vegas", 
                        "country": "United States", 
                        "state": "Nevada", 
                        "zip": "89101"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio", 
                        "zip": "45245"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma", 
                        "zip": "73103"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Eugene", 
                        "country": "United States", 
                        "state": "Oregon", 
                        "zip": "97404"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Corpus Christi", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78404"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Katy", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "77450"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salt Lake City", 
                        "country": "United States", 
                        "state": "Utah", 
                        "zip": "84107"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Renton", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "98057"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Spokane", 
                        "country": "United States", 
                        "state": "Washington", 
                        "zip": "99202"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lenasia South", 
                        "country": "South Africa", 
                        "state": "Gauteng", 
                        "zip": "1829"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Soweto", 
                        "country": "South Africa", 
                        "state": "Gauteng", 
                        "zip": "1818"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durban", 
                        "country": "South Africa", 
                        "state": "KwaZulu-Natal", 
                        "zip": "4091"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cape Town", 
                        "country": "South Africa", 
                        "state": "Western Cape", 
                        "zip": "7700"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Parow, Cape Town", 
                        "country": "South Africa", 
                        "state": "Western Cape", 
                        "zip": "7500"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Western Cape", 
                        "country": "South Africa", 
                        "zip": "7130"
                    }, 
                    "name": "Isis Investigational Site"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "South Africa"
            ]
        }, 
        "number_of_arms": "3", 
        "official_title": "A Double Blind, Placebo-Controlled, Phase 2 Study to Assess the Safety, Tolerability and Efficacy of ISIS 449884 Administered Once Weekly to Patients With Type 2 Diabetes Mellitus Being Treated With Metformin", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "United States: Food and Drug Administration", 
                "South Africa: Medicines Control Council"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Change from Baseline to Week 14", 
            "measure": "The effect of ISIS-GCGRRx on serum fructosamine", 
            "safety_issue": "No", 
            "time_frame": "14 Weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01885260"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "By determining the incidence, severity, dose-relationship adverse effects, and changes in laboratory evaluations", 
                "measure": "The safety of ISIS-GCGRRx", 
                "safety_issue": "Yes", 
                "time_frame": "25 Weeks"
            }, 
            {
                "description": "By determining the incidence, severity, dose-relationship adverse effects, and changes in laboratory evaluations", 
                "measure": "The tolerability of ISIS-GCGRRx", 
                "safety_issue": "No", 
                "time_frame": "25 Weeks"
            }
        ], 
        "source": "Isis Pharmaceuticals", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Isis Pharmaceuticals", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Pharmacodynamics Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}